Castleview Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$387K Buy
+4,537
New +$404K 0.2% 117
2025
Q3
Sell
-2,399
Closed -$218K 180
2025
Q2
$218K Buy
2,399
+222
+10% +$20.3K 0.14% 163
2025
Q1
$204K Buy
2,177
+82
+4% +$7.34K 0.14% 168
2024
Q4
$190K Buy
2,095
+245
+13% +$23.4K 0.1% 190
2024
Q3
$192K Buy
1,850
+94
+5% +$9.58K 0.11% 178
2024
Q2
$170K Sell
1,756
-225
-11% -$20.8K 0.1% 185
2024
Q1
$178K Buy
1,981
+522
+36% +$44.2K 0.1% 192
2023
Q4
$116K Sell
1,459
-1
-0.1% -$75 0.08% 193
2023
Q3
$104K Sell
1,460
-148
-9% -$11.1K 0.1% 175
2023
Q2
$124K Sell
1,608
-1,000
-38% -$77.4K 0.11% 161
2023
Q1
$196K Buy
2,608
+114
+5% +$8.48K 0.17% 131
2022
Q4
$196K Buy
2,494
+189
+8% +$14.2K 0.19% 125
2022
Q3
$162K Sell
2,305
-879
-28% -$68.9K 0.15% 140
2022
Q2
$125K Buy
3,184
+744
+30% +$58.2K 0.1% 187
2022
Q1
$185K Sell
2,440
-201,778
-99% -$16M 0.12% 178
2021
Q4
$2.39K Buy
+204,218
New +$15.9M 0.02% 257
2021
Q2
$110K Buy
+1,355
New +$111K 0.05% 274

Other funds holding CL

Castleview Partners's CL Position: Q1 2026 in Review

Castleview Partners opened a new position in Colgate-Palmolive (CL) in Q1 2026: 4,537 shares worth $387K. The stake represents 0.2% of the portfolio and ranks #117 among its holdings. This is a return to the name: Castleview Partners previously reported a position in CL as recently as Q2 2025.

Castleview Partners first reported a position in CL in Q2 2021 and has held it in 17 quarters since. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Castleview Partners held 4,537 shares of Colgate-Palmolive worth $387K as of Q1 2026.
  • Colgate-Palmolive was a new Castleview Partners position in Q1 2026.
  • Colgate-Palmolive made up 0.2% of Castleview Partners's portfolio in Q1 2026, its #117 holding.
  • Castleview Partners first reported a position in Colgate-Palmolive in Q2 2021 and has held it in 17 quarters since.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Castleview Partners's 13F filing for Q1 2026, filed 1 May 2026.